No headlines found.
Globe Newswire (Tue, 9-Jun 7:00 AM ET)
Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal
Globe Newswire (Mon, 8-Jun 7:05 AM ET)
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
Globe Newswire (Mon, 8-Jun 7:00 AM ET)
Globe Newswire (Wed, 3-Jun 6:00 AM ET)
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
Globe Newswire (Mon, 1-Jun 6:00 AM ET)
Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal
Globe Newswire (Thu, 28-May 2:49 PM ET)
Globe Newswire (Thu, 7-May 6:00 AM ET)
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
Globe Newswire (Wed, 6-May 6:00 AM ET)
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine
Globe Newswire (Tue, 5-May 6:00 AM ET)
Globe Newswire (Thu, 30-Apr 6:00 AM ET)
Aclarion - Warrant trades on the stock market under the symbol ACONW.
As of June 9, 2026, ACONW stock price was flat at $0.03 with 4,520 million shares trading.
ACONW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, ACONW traded as high as $.33 and as low as $.01.
ACONW has underperformed the market in the last year with a price return of -20.0% while the SPY ETF gained +24.3%. ACONW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.4% and -7.3%, respectively, while the SPY returned +9.9% and -1.2%, respectively.
ACONW support price is $.03 and resistance is $.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACONW shares will trade within this expected range on the day.
